What Does it Cover?
Did you know that the incidence of liver cancer has tripled since 1980? Have you wondered what current antibodies are being used to label liver carcinomas by IHC? Or are you curious what antibody grids are used in the differential of primary liver carcinoma? In this presentation, we will discuss the markers used in detecting liver carcinoma as well as other antibody grids that can be run to aid in the identification of primary liver carcinoma.
What Will You Learn?
- Specific antibodies used to identify liver cancer
- The antibody grids used for liver carcinomas
Who Should Attend?
- Pathologists
- Histotechnologists
- Pathology Residents
- Histology Students
- Lab Managers
- IHC Technicians
- Health Care Professionals
Speakers
Brett Merritt
Merck
Account Manager
Brett Merritt has been a Technical Consultant with Cell Marque-Merck for a little over a year. His territory includes PA, NJ, and DE. He was born and raised in the central valley of California where he received his B.S. in Biology. He currently lives in Antelope, CA, near Cell Marque’s headquarters. In his spare time, he is likely to be found with his wife and two kids going on adventures.
Webinar Information
Protein biology
- Immunohistochemistry
Research and disease areas
- Cancer research
Duration:1h 4min
Language:English
Presented:Wed, April 10, 2019
To continue reading please sign in or create an account.
Don't Have An Account?